[FURL=https://www.industryarc.com/Research/Head-And-Neck-Cancer-Drugs-Therapeutics-Market-Research-508729]Head and Neck Cancer Drugs Therapeutics Market[/FURL] size was valued at $ 1.45 Billion by 2019, and is anticipated to grow at a CAGR of 8.65% during the forecast period 2020-2025. The Head and Neck Cancer Therapeutics Market growth rate is attributed to development of innovative and cost-effective treatments, numerous side effects related to radiation therapy and chemotherapy, increased healthcare expenditure, and better government initiatives are poised to accelerate the growth of the market in the forecast period of 2020-2025. A variety of different malignant tumors that form in or around the throat, larynx, nose, sinuses, tongue, salivary glands, and mouth include head & neck cancers. For the treatment of head & neck cancer, there are various types of used individually or in combination. Targeted immune therapies are emerging as a standard treatment choice for advanced-stage head & neck cancers, while conventional chemotherapeutic are preferably used in combination with radiation therapy.Key Takeaways
North America dominated the Head and Neck Cancer Drugs/Therapeutics Market with a share of 38.65% in the year 2019.
The factors such as growing geriatric population, huge research funding in oncology and unmet medical needs are amongst the major factor projected to impel growth of Head and Neck Cancer Drugs/Therapeutics Market.
Constant increase in prevalence of head & neck cancer across geographies, rise in demand for combination therapy for management of head & neck cancer, and growth in number of R&D activities to develop ideal therapeutic are the key factors owing to the growth in the segment during forecast period 2020-2025.
Request for Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508729[/FURL]
Head and Neck Cancer Therapeutics Market Segment Analysis - By Geography
North America dominated the Head and Neck Cancer Therapeutics Market with a share of 38.65% in 2019. The application of Head and Neck Cancer Therapeutics has grown rapidly over the last few years owing to the presence of patient population, increasing prevalence of head and neck cancer, well-developed technology, high healthcare expenditure, and the presence of leading market players.
Head and Neck Cancer Therapeutics Market Drivers
Increase in immunotherapy adoption by several countries across the world
Head and Neck Cancer Therapeutics Market top 10 companies are AB Science SA, AbbVie Inc., Acceleron Pharma, Inc., AdDent Inc., ASAHI Roentgen, Astellas Pharma Inc., AstraZeneca Plc., Bayer AG, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Carestream, Fujifilm Holdings, GE Healthcare, Identafi, Koninklijke Philips N.V., and others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.